The following equity analysts have regular coverage on Faron Pharmaceuticals on their own initiative. The list may be incomplete. Faron is not responsible for their views.
Panmure Gordon, Julie Simmonds, julie.simmonds@panmure.com
Kepler Chevreaux, Jon Berggren, jberggren@keplercheuvreux.com
Peel Hunt, Miles Dixon, miles.dixon@peelhunt.com
Redeye, Kevin Sule, kevin.sule@redeye.se
Inderes, Antti Siltanen, antti.siltanen@inderes.fi
H.C.WAINWRIGHT&CO, Patrick R, Trucchio, ptrucchio@hcwresearch.com
The information above is disclosed in accordance with Rule 26 of the AIM Rules for Companies.